William R Jellison Avient Corp (AVNT) insider trading activity

William R Jellison is Director of AVIENT CORP. Currently has a direct ownership of 22,622 shares of AVNT, which is worth approximately $747,204. The most recent transaction as insider was on Jun 30, 2025, when has been sold 1,187 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.6K

5.54% 3M change

21.3% 12M change

Total Value Held $747,204

William R Jellison Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 30 2025	BUY Grant, award, or other acquisition	-	1,187 Added 4.99%	22,622 Common Stock
Mar 31 2025	BUY Grant, award, or other acquisition	-	1,055 Added 4.69%	21,435 Common Stock
Dec 31 2024	BUY Grant, award, or other acquisition	-	955 Added 4.48%	20,380 Common Stock
Sep 30 2024	BUY Grant, award, or other acquisition	-	775 Added 3.84%	19,425 Common Stock
Jun 28 2024	BUY Grant, award, or other acquisition	-	806 Added 4.14%	18,650 Common Stock
Mar 29 2024	BUY Grant, award, or other acquisition	-	808 Added 4.33%	17,844 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	-	834 Added 4.67%	17,036 Common Stock
Sep 29 2023	BUY Grant, award, or other acquisition	-	984 Added 5.73%	16,202 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	-	863 Added 5.37%	15,218 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	-	857 Added 5.63%	14,355 Common Stock
Dec 31 2022	BUY Grant, award, or other acquisition	-	1,040 Added 7.15%	13,498 Common Stock
Sep 30 2022	BUY Grant, award, or other acquisition	-	1,139 Added 8.38%	12,458 Common Stock
Sep 30 2022	BUY Grant, award, or other acquisition	-	1,139 Added 8.38%	12,458 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	-	880 Added 7.21%	11,319 Common Stock
Mar 31 2022	BUY Grant, award, or other acquisition	-	717 Added 6.43%	10,439 Common Stock
Dec 31 2021	BUY Grant, award, or other acquisition	-	627 Added 6.06%	9,722 Common Stock
Sep 30 2021	BUY Grant, award, or other acquisition	-	744 Added 7.56%	9,095 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	-	669 Added 7.42%	8,351 Common Stock
Mar 31 2021	BUY Grant, award, or other acquisition	-	682 Added 8.15%	7,682 Common Stock

Also insider at

ANIK

Anika Therapeutics, Inc. Healthcare

Director

MASI

MASIMO CORP Healthcare

Director

WRJ